First-in-human Section 1a/1b medical trial will consider orally accessible, RGT-61159 designed to selectively goal MYB RNA and inhibit oncogenic MYB protein manufacturing
Preclinical...
In sufferers with uncommon histological PCa subtypes, it's unknown what quantity of deaths could also be attributable to PCa (CSM) and what quantity...